Phenprocoumon
Phenprocoumon (marketed under the brand names Marcoumar, Marcumar and Falithrom) is a long-acting blood thinner drug to be taken by mouth, and a coumarin derivative. It acts as a vitamin K antagonist and inhibits blood clotting (coagulation) by blocking synthesis of coagulation factors II, VII, IX and X. It is used for the prophylaxis and treatment of thromboembolic disorders such as heart attacks and pulmonary (lung) embolism. The most common adverse effect is bleeding. The drug interacts with a large number of other medications, including aspirin and St John's Wort. It is the standard coumarin used in Germany, Austria, and other European countries.
Clinical data | |
---|---|
Trade names | Marcoumar, Marcumar, Falithrom |
AHFS/Drugs.com | International Drug Names |
MedlinePlus | a699003 |
Pregnancy category | |
Routes of administration | By mouth |
ATC code | |
Legal status | |
Legal status |
|
Pharmacokinetic data | |
Bioavailability | 100% |
Protein binding | 99% |
Metabolism | Liver (CYP2C9, CYP3A4) |
Metabolites | Hydroxyl derivatives, glucuronides |
Elimination half-life | 6–7 days |
Excretion | Kidney |
Identifiers | |
| |
CAS Number | |
PubChem CID | |
IUPHAR/BPS | |
DrugBank | |
ChemSpider | |
UNII | |
KEGG | |
ChEBI | |
ChEMBL | |
CompTox Dashboard (EPA) | |
ECHA InfoCard | 100.006.464 |
Chemical and physical data | |
Formula | C18H16O3 |
Molar mass | 280.323 g·mol−1 |
3D model (JSmol) | |
Melting point | 177–181 °C (351–358 °F) |
| |
| |
(verify) |
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.